Health Care: Drugs

Celgene Corporation (CELG: NASDAQ)

$141.51 n/a | n/a%
04/17/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 141.51
52 Week High 174.66
52 Week Low 110.53
Avg. Daily Vol. (Mil) 3.91
Beta (3 year) 1.08
Share Related Items
Mkt Cap (Mil) 57,455.90
Shares Out (Mil) 406.02
Float (Mil) 416.68
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.50
Current Ratio 3.90
LT Debt/ Equity 0.75
Total Debt / Equity 0.85
Valuation Ratios
Price Earnings 42.00
Price/Sales 8.85
Price/Book 10.28
Price/Cash Flow 31.50
Per Share Data
Earnings 3.37
Sales 15.99
Book Value 13.77
Cash Flow 4.49
Business Summary
Celgene Corporation is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
General Information
86 Morris Avenue
Summit, NJ 07901
www.celgene.com
Industry : Drugs
Sector: Health Care
Employees: 5100
CEO: Robert J. Hugin
Short Interest
Current Month (Mil) 5.75
Previous Month (Mil) 6.12
Short Interest Ratio (Days) 1.40
Management Effectiveness
Return on Equity 25.90
Return on Assets 10.80
Return on Investments 14.80
Profitability
Gross Margin 96.50
EBIT Margin 27.10
Profit Margin 22.30

Portfolios with CELG

Latest CELG Headlines from TheStreet

More Financial News for CELG

Press Releases for CELG

See All Press Releases

Partner Headlines for CELG

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter